Maternal Toxicity With Continuous Nevirapine in Pregnancy-Reference-Cited by-同舟云学术

Maternal Toxicity With Continuous Nevirapine in Pregnancy

Published:2004-07 Issue:3 Volume:36 Page:772-776
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes

Author:

Hitti Jane,Frenkel Lisa M.,Stek Alice M.,Nachman Sharon A.,Baker David,Gonzalez-Garcia Adolfo,Provisor Arthur,Thorpe Edwin M.,Paul Mary E.,Foca Marc,Gandia Jorge,Huang Sharon,Wei Lee-Jen,Stevens Laura M.,Watts D. Heather,McNamara James

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference8 articles.

1. Drug-Induced Hepatotoxicity

2. Fatal liver failure associated with Nevirapine in a pregnant HIV patient: The first reported case

3. Drug rash with eosinophilia and systemic symptoms syndrome and renal toxicity with a nevirapine-containing regimen in a pregnant patient with human immunodeficiency virus*1

4. A Comprehensive Hepatic Safety Analysis of Nevirapine in Different Populations of HIV Infected Patients*

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ABCG2 polymorphisms and susceptibility to ARV‐associated hepatotoxicity;Molecular Genetics & Genomic Medicine;2024-03

2. NNRTI and Liver Damage: Evidence of Their Association and the Mechanisms Involved;Cells;2021-07-04

3. Stevens-Johnson syndrome and toxic epidermal necrolysis in pregnant patients: A systematic review;International Journal of Women's Dermatology;2020-09

4. Prevention of Mother to Child Transmission of HIV;HIV Infection in Children and Adolescents;2020

5. Liver Enzyme Elevation in Pregnant Women Receiving Antiretroviral Therapy in the ANRS-French Perinatal Cohort;JAIDS Journal of Acquired Immune Deficiency Syndromes;2019-05-01